The Migraine Trust

News

AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, after a NICE decision.

News

Lundbeck’s eptinezumab receives NICE recommendation for the prevention of migraine in adults.

News

In another blow to its late-stage pipeline, AstraZeneca has pulled the plug on a phase 3 trial of its lung cancer treatment volrustomig.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.